Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation (Rashi Shrivastava/Forbes)

Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation. Scientists at manufacturing conglomerates like Kenvue and Henkel use Albert Invent's AI tools to design experiments.